Trademark Overview
On Thursday, May 29, 2025, a trademark application was filed for TDI with the United States Patent and Trademark Office. The USPTO has given the TDI trademark a serial number of 99208486. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, February 24, 2026. This trademark is owned by APERIO CLINICAL OUTCOMES LLC. The TDI trademark is filed in the Advertising, Business and Retail Services and Computer & Software Services & Scientific Services categories with the following description:
Scientific data analysis, namely, analysis of clinical trial data in the pharmaceutical, biotechnology and life sciences fields; Scientific research services, namely, accessing, collecting, managing, tracking, analyzing, and reporting research data in the pharmaceutical and life sciences fields; Scientific research consulting services, namely, collecting, managing, and analyzing clinical trial data; Consulting services for others in the field of design, planning, and implementation of clinical trials, clinical trial simulation, and clinical trial data review; Contract research organization (CRO) services, namely, scientific research in the nature of conducting clinical trials for investigational drugs of biotech and pharmaceutical companies for others, and quality assurance services for others in the fields of data management, electronic data capture (EDC) database programming of clinical trial, and data analytics for others; Consulting services in the field of conducting clinical tria...
Database management and data processing services in the pharmaceutical and life sciences fields; business data analytics and data management services being data processing for business purposes in the pharmaceutical and life sciences fields of clinical research; Business consulting and management in the field of clinical trials, namely, clinical data management on behalf of pharmaceutical and life sciences companies to assist them with clinical research and clinical trials; Providing independent review of clinical trial data for clinical trial purposes for business purposes
